Susquehanna Portfolio Strategies »

Zentalis Pharmaceuticals shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2026-06-30 $544k 112k 4.85

More positions owned by Susquehanna Portfolio Strategies

Intel Corporation (INTC)
Abbvie (ABBV)
Sherwin-Williams Company (SHW)
Medtronic SHS (MDT)
Philip Morris International (PM)
Starbucks Corporation (SBUX)
Costco Wholesale Corporation (COST)
Humana (HUM)
Prologis (PLD)
Williams Companies (WMB)
Devon Energy Corporation (DVN)
Equinix (EQIX)
Metropcs Communications (TMUS)
Monster Beverage Corp (MNST)
Cigna Corp (CI)

View all positions for Susquehanna Portfolio Strategies

Top funds holding Zentalis Pharmaceuticals

Squadron Capital Management
5AM Venture Management
BlackRock
Two Sigma Investments
Vanguard Capital Management
Acadian Asset Management
Citadel Advisors
Renaissance Technologies
Opaleye Management
OrbiMed Advisors
Decheng Capital
Geode Capital Management
Bank of America Corporation
PRIMECAP Management Company
Pfizer

View all funds holding Zentalis Pharmaceuticals